Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W O Bechstein

Showing results (191-200 of 351) with videos related to

Pageof 36
Sort By:
Transplantation Proceedings|May 17, 2000
Infectious complications after orthotopic liver transplantation with different immunosuppressive induction regimensR Lohmann, J M Langrehr, J Klupp, et al.
Surgery|April 1, 1997
Female sex hormone receptor status in advanced hepatocellular carcinoma and outcome after surgical resectionS Jonas, W O Bechstein, T Heinze, et al.
Transplantation Proceedings|June 24, 1998
Donor-recipient sex matching and posttransplant malignancies after induction therapy in hepatic transplantationS Jonas, U Neumann, O Guckelberger, et al.
Transplantation|August 13, 1998
Pretransplant virological markers hepatitis C virus genotype and viremia level are not helpful in predicting individual outcome after orthotopic liver transplantationT Berg, U Hopf, W O Bechstein, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 26, 2000
Lamivudine as first- and second-line treatment of hepatitis B infection after liver transplantationD Seehofer, N Rayes, T Berg, et al.
Transplantation Proceedings|May 30, 2001
Chronic rejection after orthotopic liver transplantation is increased under induction therapy with interleukin-2 receptor antibody BT563J M Langrehr, R Lohmann, R Raakow, et al.
Transplantation Proceedings|April 1, 1993
Quadruple induction immunosuppression after liver transplantation with interleukin-2 receptor antibody (BT 563) is equally effective and better tolerated than antithymocyte globulin induction therapyP Neuhaus, W O Bechstein, G Blumhardt, et al.
Transplantation|June 3, 2000
Additional interferon alpha for lamivudine resistant hepatitis B infection after liver transplantation: a preliminary reportD Seehofer, N Rayes, T Berg, et al.
Clinical Transplantation|June 1, 1995
Toxicity versus rejection--or why conversions between cyclosporine A and FK506 were performed after liver transplantationK P Platz, A R Mueller, S Jonas, et al.
Transplantation Proceedings|August 1, 1993
Induction therapy with anti-T-lymphocyte globulin following orthotopic liver transplantationN Schattenfroh, D Lange, W O Bechstein, et al.
Pageof 36

Showing results (191-200 of 351) with videos related to

Sort By:
Pageof 36
Transplantation Proceedings|May 17, 2000
Infectious complications after orthotopic liver transplantation with different immunosuppressive induction regimensR Lohmann, J M Langrehr, J Klupp, et al.
Surgery|April 1, 1997
Female sex hormone receptor status in advanced hepatocellular carcinoma and outcome after surgical resectionS Jonas, W O Bechstein, T Heinze, et al.
Transplantation Proceedings|June 24, 1998
Donor-recipient sex matching and posttransplant malignancies after induction therapy in hepatic transplantationS Jonas, U Neumann, O Guckelberger, et al.
Transplantation|August 13, 1998
Pretransplant virological markers hepatitis C virus genotype and viremia level are not helpful in predicting individual outcome after orthotopic liver transplantationT Berg, U Hopf, W O Bechstein, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 26, 2000
Lamivudine as first- and second-line treatment of hepatitis B infection after liver transplantationD Seehofer, N Rayes, T Berg, et al.
Transplantation Proceedings|May 30, 2001
Chronic rejection after orthotopic liver transplantation is increased under induction therapy with interleukin-2 receptor antibody BT563J M Langrehr, R Lohmann, R Raakow, et al.
Transplantation Proceedings|April 1, 1993
Quadruple induction immunosuppression after liver transplantation with interleukin-2 receptor antibody (BT 563) is equally effective and better tolerated than antithymocyte globulin induction therapyP Neuhaus, W O Bechstein, G Blumhardt, et al.
Transplantation|June 3, 2000
Additional interferon alpha for lamivudine resistant hepatitis B infection after liver transplantation: a preliminary reportD Seehofer, N Rayes, T Berg, et al.
Clinical Transplantation|June 1, 1995
Toxicity versus rejection--or why conversions between cyclosporine A and FK506 were performed after liver transplantationK P Platz, A R Mueller, S Jonas, et al.
Transplantation Proceedings|August 1, 1993
Induction therapy with anti-T-lymphocyte globulin following orthotopic liver transplantationN Schattenfroh, D Lange, W O Bechstein, et al.
Pageof 36